“Anti-CD20 Therapy and Disability Progression in Relapsing Multiple Sclerosis”. Current Research in Neurology and Neurosurgery, vol. 7, no. 1, July 2024, pp. 17-24, https://doi.org/10.5281/zenodo.22310428.